We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endoscopic Procedure Improves GERD Symptoms

By HospiMedica staff writers
Posted on 18 Apr 2001
A study has concluded that a new treatment for gastroesophageal reflux disease (GERD) significantly improved symptoms, quality of life, and esophageal acid exposure while eliminating the need for acid-reducing medication A study has concluded that a new treatment for gastroesophageal reflux disease (GERD) significantly improved symptoms, quality of life, and esophageal acid exposure while eliminating the need for acid-reducing medication in the majority of patients. More...
The study was published in the April issue of Gastrointestinal Endoscopy.

The treatment, called the Stretta Procedure, is a minimally invasive, outpatient encodscopic procedure performed in 60 minutes or less. Using a flexible, disposable catheter connected to a radiofrequency (RF) generator, the doctor delivers controlled RF energy to the lower esophageal sphincter (LES) muscle and gastric cardia to create thermal lesions. As the lesions heal, the barrier function of the LES is enhanced, reducing the frequency of reflux events. The procedure was developed by Curon Medical, Inc. (Sunnyvale, CA, USA).

"Critically, a majority of the patients experienced such remarkable improvement that they no longer required the use of acid-reducing drugs,” said George Triadafilopoulos, professor of medicine at Stanford University and lead author of the study. "This is a significant advance in the treatment of this widespread and distressing disease.”




Related Links:
Curon Medical

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.